The aim of this study was to evaluate HS1 expression in CLL patients in connection with other known prognostic factors and patients鈥?survival.
90 untreated CLL patients were included into the study. The control group consisted of 28 healthy matched people. HS1 detection was performed by western-blotting. Mutational status of IgVH, as well as CD38 and ZAP70 expression was also analyzed.
HS1 expression was significantly higher in CLL patients comparing to controls. Positive correlation was shown between HS1 and: age (p = 0.0454), Rai stage (p = 0.0412), leukocytosis (p = 0.0129) and beta-2-microglobulin (p = 0.0342). Patients with lymphocyte doubling time shorter or equal to 6 months had higher expression of HS1. Patients with higher HS1 expression had shorter survival than those with lower HS1 expression (p = 0.0329).
We showed, that high HS1 expression predicts poor survival of chronic lymphocytic leukemia patients.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址:北京市海淀区学院路29号 邮编:100083 电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700 |